12:00 AM
 | 
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

ADAMTS13 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for ADAMTS13...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >